HIT Consultant March 14, 2025
Fred Pennic

What You Should Know:

– The recent acquisition of Walgreens Boots Alliance by private equity firm Sycamore Partners is drawing scrutiny due to the high level of debt financing involved and questions surrounding Sycamore’s equity commitment.

– According to a Securities and Exchange Commission (SEC) filing, 83.4% of the financing for the Walgreens buyout is debt, totaling $22.5B. This is more than double the average debt level (41%) used in private equity acquisitions last year.

PESP Raises Alarms About Potential Risks

The non-profit watchdog Private Equity Stakeholder Project (PESP) has released a statement expressing concern about the leveraged buyout of Walgreens. PESP emphasizes the risks associated with private equity investment in healthcare companies, citing the potential for:

  • Increased...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Investments, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Pharma Pulse 3/14/25: Navigating Internal Constraints and Uncertainty, Health Plan Support During Natural Disasters & more
Azurity Pharmaceuticals Completes Covis Pharma Acquisition
Over 300 Pharmacy Closures Reported in the Last 3 Months
Pharmacists Can Act as Navigators for Patients Using Digital Health Tools
Sutro puts lead ADC on hold, cuts staff and changes CEO

Share This Article